Onsdag 18 November | 10:32:59 Europe / Stockholm
Est. tid*
2027-02-24 08:30 Bokslutskommuniké 2026
2026-11-12 - 15-6 2026
2026-11-03 - Extra Bolagsstämma 2026
2026-08-14 - Kvartalsrapport 2026-Q2
2026-05-31 - Kvartalsrapport 2026-Q1
2026-05-27 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2026-05-26 - Årsstämma
2026-03-27 - Bokslutskommuniké 2025
2025-11-14 - Kvartalsrapport 2025-Q3
2025-08-01 - Kvartalsrapport 2025-Q2
2025-05-27 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2025-05-26 - Årsstämma
2025-05-22 - Kvartalsrapport 2025-Q1
2025-03-27 - Bokslutskommuniké 2024
2024-12-30 - Extra Bolagsstämma 2025
2024-10-24 - Kvartalsrapport 2024-Q3
2024-10-04 - Extra Bolagsstämma 2024
2024-07-18 - Kvartalsrapport 2024-Q2
2024-04-26 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2024-04-25 - Årsstämma
2024-04-18 - Kvartalsrapport 2024-Q1
2024-02-16 - Bokslutskommuniké 2023
2023-10-25 - Kvartalsrapport 2023-Q3
2023-07-18 - Kvartalsrapport 2023-Q2
2023-04-27 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2023-04-26 - Årsstämma
2023-02-16 - Bokslutskommuniké 2022
2022-11-09 - Kvartalsrapport 2022-Q3
2022-08-17 - Kvartalsrapport 2022-Q2
2022-05-19 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2022-05-17 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-12-14 - Extra Bolagsstämma 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-17 - Kvartalsrapport 2021-Q2
2021-05-14 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2021-04-18 - Årsstämma
2021-02-25 - Bokslutskommuniké 2020
2020-11-27 - Extra Bolagsstämma 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-07-14 - Kvartalsrapport 2020-Q2
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Magle Chemoswed bygger på strategiska förvärv som syftar till att driva tillväxt och diversifiera risker. Koncernen omfattar tre verksamhetsområden. Magle Chemoswed, en kontraktsutvecklings- och tillverkningsorganisation (CDMO). Magle PharmaCept, ett försäljnings- och marknadsföringsföretag för utveckling och direktförsäljning av koncernens medicintekniska produkter, och Magle Biopolymers A/S, en specialiserad tillverkningsorganisation för Dextran-teknologi.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Magle Chemoswed Holding AB (publ) initiates a written procedure in order to utilise the option to pay PIK Interest under its super senior secured fixed rate bonds

2026-11-17 13:55:00

Magle Chemoswed Holding AB (publ) (the "Company") hereby announces that it, through Nordic Trustee & Agency AB (publ) as agent (the “Agent”) under its super senior secured fixed rate bonds with ISIN NO0013758086 (the "Bonds"), has initiated a written procedure (the "Written Procedure") in order to enable Bondholders to vote for or against the Company's request to utilise the PIK Component for the current Interest Period which ends on 1 December 2026 (with Interest Payment Date occurring on 2 December 2026).

Pursuant to the Terms and Conditions of the Bonds, the Company may elect to pay a part of the Interest under the Bonds as PIK Interest, subject to the Company giving prior notice of no less than 10 CSD Business Days' before the first day of the relevant Interest Period. For the current Interest Period the deadline for serving a notice to elect PIK Interest expired before the issuance of the Bonds and it was therefore not technically possible for the Company to elect the option to pay PIK Interest for the current Interest Period. It is against this background that the Company has initiated the Written Procedure.

 

Voting Information
 
To be eligible to participate in the Written Procedure, a person must be a holder of Bonds on 19 November 2026, meaning that the person must be registered on a securities account with Verdipapirsentralen ASA (Euronext Securities Oslo) as a direct registered owner or authorised nominee with respect to one or several Bonds.
 
The Agent must receive the voting form no later than 14:00 CET on 2 December 2026 either by mail, courier or email to the Agent using the contact details set out in Section 4.6 in the notice of the Written Procedure. Votes received thereafter may be disregarded.
 
For further information regarding the Written Procedure and the requests, including the full details of the proposal, please refer to the notice of Written Procedure available on the Company's website (https://maglegroup.com/) and via the Agent's information service Stamdata (https://stamdata.com/).